Vo
lu
m
e
5,
Ap
ri
l,
20
25
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
GENERAL PRINCIPLES OF ORGAN AND TISSUE TRANSPLANTATION: THE
CONCEPT OF TRANSPLANTOLOGY AND PROSTHETICS
Mamanov Baxtishod Sirojiddin ugli,
Egamurodov Shohjahon Olim ugli,
Hasanov Muhammad Yusuf ugli,
Obidov Og'abek Toxir ugli,
Students of Tashkent State Dental Institute
Gadayev Asliddin Mamarasulovich
Scientific Supervisor of the Department of Anatomy
Annotation:
This article discusses the general principles of organ and tissue transplantation,
focusing on the concepts of transplantology and prosthetics. Organ and tissue transplantation
represents one of the most advanced and life-saving branches of modern medicine. The
paper analyzes the fundamental principles of transplantology, including ethical, clinical, and
technological aspects. Special attention is given to donor selection, immunological
compatibility, and the long-term viability of the transplanted organ. The article also
highlights global disparities in access to transplantation services and emphasizes the
necessity of establishing a safe and equitable donor system worldwide.
Keywords:
Donor, transplantation, WHO, 3D bioprinting, tissue, biomimicry, prosthetics,
organ failure.
Introduction:
Tissue or organ donation is a complex, multidisciplinary process that
begins with a well-defined procedure for determining death. Following this, donors are
selected based on strict criteria that determine whether or not organ retrieval is permissible.
As a result, this process involves highly specialized medical teams who perform organ
retrieval and transplantation. This article sheds light on
the role of the medical team in evaluating and managing the donation process, as well as in
post-transplant patient care.
Objectives:
To promote organ donation and support efforts to improve outcomes.
To discuss strategies for enhancing coordination and communication among medical
teams.
To summarize the barriers in tissue and organ donation.
To examine the role of healthcare professionals in the donation process.
Tissues and organs can be donated by either living or deceased donors.
Living donors
typically donate organs such as a kidney, a portion of the liver, or a lobe of the lung.
According to the U.S. Institute of Medicine – National Academy of Sciences, physicians
may determine death based on neurological (brain death) or circulatory-respiratory criteria.
Once death has been confirmed, certain organs may be retrieved from the donor’s div and
transplanted into a recipient in need.
Vo
lu
m
e
5,
Ap
ri
l,
20
25
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
Unfortunately, thousands of patients around the world suffer or lose their lives each day due
to the lack of available organs and tissues for transplantation. Healthcare professionals are
often placed in emotionally challenging situations where they must encourage families to
consider donation at the time of a loved one’s death — a decision that has the potential to
save another person’s life.
In the organ donation process, care is multifaceted.
Following the determination of death
by neurological or circulatory criteria, donor management begins with the optimization of
the donor’s physiological condition. This includes hemodynamic and ventilatory support to
preserve heart and lung function. It is essential to retrieve organs and tissues promptly, as
inflammatory mediators begin to infiltrate solid organs shortly after death, increasing their
immunogenicity and potentially reducing transplant success. Therefore, every step from
retrieval to placement must be performed swiftly and efficiently to ensure the best outcomes.
The Role of Healthcare Providers and Teams:
Some healthcare professionals may decline
to participate in tissue or organ donation or transplantation due to personal, cultural, ethical,
or religious beliefs. While it is important to respect individual belief systems, these personal
convictions should not interfere with a patient’s right to make autonomous decisions
regarding their own care. The primary obligation of medical staff is toward the patient and
their family. However, some healthcare workers may choose not to participate in the
donation process or in institutional or community awareness campaigns. This decision
should be respected as a matter of personal choice.
For those willing to support the cause, roles can range from offering guidance to patients
considering donation during end-of-life planning, to participating in education and outreach.
Key concerns for organ and tissue procurement teams
include obtaining consent,
retrieving organs and tissues promptly, and ensuring their rapid transport. Common
challenges may arise due to the inability to identify suitable donors, delayed declaration of
death, or the absence of a matching recipient at the time of availability.
Organ and tissue placement teams
are primarily concerned with the compatibility of the
tissue or organ, maintaining viability during transport and handling, and ensuring timely
transplantation into the recipient.
The first human
colon transplantation
was performed in 1964 in Boston by Deterling. In
the territory of the Russian Federation, the
first small intestine transplantation
was
successfully conducted on May 25, 2006, at the "Russian Scientific Center of Surgery
named after Academician B. V. Petrovsky." According to statistical data, nearly 3,000 small
intestine transplantations have been carried out worldwide. In high-level specialized
transplant centers, the one-year survival rate of patients exceeds 90%. The five-year survival
rate of recipients, including those who underwent
multivisceral transplantation
, reaches
up to 56%.
The
primary indication for small intestine transplantation worldwide
is
short bowel
syndrome (SBS)
. The major causes of SBS include intestinal atresia, necrotizing
enterocolitis, mesenteric thrombosis, intestinal volvulus, and the consequences of extensive
resections due to massive intussusception.
Vo
lu
m
e
5,
Ap
ri
l,
20
25
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
Prosthetics
refers to the application of artificial devices to restore the function or structure
of natural organs. Examples include heart valves, artificial knee joints, hearing aids, and
even bioelectronic hearts. Prosthetics are often used in cases where transplantation is not
feasible and are essential for restoring a patient's mobility and improving their quality of life.
In both
transplantology and prosthetics
, adherence to ethical and legal standards is crucial.
These include obtaining donor consent, combating organ trafficking, ensuring equitable
access, and maintaining a transparent waiting list system. The
World Health Organization
(WHO)
and other international bodies are actively working to establish global standards in
these areas.
Modern Achievements and Future Prospects.
Recent advancements in
3D bioprinting
,
regenerative medicine
, and the creation of artificial organs are taking the field of
transplantology to a new level. These technologies may significantly reduce the demand for
donor organs in the near future, thereby addressing organ shortages and offering patients a
better quality of life.
3D bioprinting
involves additive manufacturing (AM) techniques for producing tissues or
organs layer-by-layer. This method uses a bottom-up approach and aims to accurately
replicate the microarchitecture of natural tissues by precisely placing biomaterials and living
cells. Organs or tissues created via 3D printing resemble their natural counterparts in both
structure and function.
3D bioprinting is based on
three key approaches
:
Biomimicry
– mimicking the structure and function of natural tissues
1.
Autonomous self-assembly
– enabling cells to organize themselves into functional
structures,
2.
Mini-tissue building blocks
– using modular units to construct complex tissues.
An organ or tissue engineered through
3D printing
closely resembles complex natural organ
tissue and functions in a similar manner.
3D bioprinting
is based on three fundamental
approaches:
biomimicry
,
autonomous self-assembly
, and
the use of mini-tissue building
blocks
.
Vo
lu
m
e
5,
Ap
ri
l,
20
25
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
Conclusion:
In summary,
transplantology and prosthetics
are rapidly evolving and
intersecting branches of medical science. The synergy between these two fields not only
contributes to
life-saving interventions
but also significantly enhances
the quality of life
for patients. On a global scale, supporting these processes through the integration of
ethical
standards, legal frameworks, and technological innovations
can lead to greater efficiency
within healthcare systems.
References:
1.
Tripathi, S. et al. (2023).
3D Bioprinting and Its Innovative Approach for Biomedical
Applications
.
MedComm
, 4(1).
https://doi.org/10.1002/mco2.194
1.
National library of medicine, national center for biotechnology information.
2.
Thuong M, Ruiz A, Evrard P, Kuiper M, Boffa C, Akhtar MZ, Neuberger J, Ploeg
R. New classification of donation after circulatory death donors definitions and terminology.
Transpl Int. 2016 Jul;29(7):749-59. [PubMed]
